continuingmedicaleducation

Continuing medical education (CME) credits are the sort of things that you forget about and then a few weeks before they're due, you remember and start to panic. With CMEfy and Adaptrack, you don't have to worry about these things anymore. You'd be able to make these micro-learnings that you have within your day count as credits. The goal is to make it as seamless as possible. Join your host Samuel Gbadebo as he talks to the Chief Medical Officer of Adaptrack, Dr. Brian Cohen. Learn more about CMEfy, Adaptrack, and how to use them. Love the show? Subscribe, rate, review, and share!

• Here’s How »

Join the Medical Sales Podcast Community today:

• evolveyoursuccess.com

Are you a Healtcare Provider? Reflect on how this Podcast applies to your day-to-day and earn AMA PRA Category 1 CMEs here:

• https://earnc.me/jdSC5n

Listen as we interview Diane Bartoli on the current and future state of eCME, what impacts COVID has had, and where she expects eCME to to post COVID.

In this podcast, expert clinicians will discuss recent clinical evidence supporting optimal treatment selection for patients with progressive MS.

Retinal vein occlusions (RVOs) are the second most common retinal vascular disorder after diabetic retinopathy. The early and accurate diagnosis of RVO is paramount so that therapy can be initiated in a timely manner to prevent vision decline. Newer imaging technologies integrated into current diagnostic algorithms are aiding in the diagnosis of RVO and guiding therapy. Further, significant visual and anatomic improvements have been demonstrated with anti-vascular endothelial growth factor (VEGF) therapies in patients with central or branch RVO-related macular edema, and refinement of treatment protocols have the potential to further enhance outcomes as well as reduce treatment burden. In this curbside consult, Drs. Carl Regillo and Christina Weng assess the effect of treating RVO early in its course for the improvement of visual outcomes.

Retinal vein occlusions (RVOs) are the second most common retinal vascular disorder after diabetic retinopathy. The early and accurate diagnosis of RVO is paramount so that therapy can be initiated in a timely manner to prevent vision decline. Newer imaging technologies integrated into current diagnostic algorithms are aiding in the diagnosis of RVO and guiding therapy. Further, significant visual and anatomic improvements have been demonstrated with anti-vascular endothelial growth factor (VEGF) therapies in patients with central or branch RVO-related macular edema, and refinement of treatment protocols have the potential to further enhance outcomes as well as reduce treatment burden. In this curbside consult, Drs. Carl Regillo and David Eichenbaum examine innovations in imaging that can improve the monitoring of treatment response in patients with RVO.

Retinal vein occlusions (RVOs) are the second most common retinal vascular disorder after diabetic retinopathy. The early and accurate diagnosis of RVO is paramount so that therapy can be initiated in a timely manner to prevent vision decline. Newer imaging technologies integrated into current diagnostic algorithms are aiding in the diagnosis of RVO and guiding therapy. Further, significant visual and anatomic improvements have been demonstrated with anti-vascular endothelial growth factor (VEGF) therapies in patients with central or branch RVO-related macular edema, and refinement of treatment protocols have the potential to further enhance outcomes as well as reduce treatment burden. In this curbside consult, Drs. Carl Regillo and David Eichenbaum discuss how advances in the treatment of RVO achieved in clinical trials can be applied to real-world practice.

In this podcast, expert clinicians will discuss the importance of a multidisciplinary team approach when managing patients receiving neuromuscular blockade therapy.

In this podcast, expert clinicians will discuss the clinical data supporting the use of current and investigational neuromuscular blockade agents.

In this podcast, expert clinicians will discuss the benefits and limitations of conventional reversal agents.

In this podcast, expert clinicians will discuss the best practices for monitoring patients receiving neuromuscular blockade agents.

In this podcast, expert clinicians will share procedural pearls for PFO closure and important considerations to optimize patient outcomes. 

In this podcast, expert clinicians will discuss management of patients with cryptogenic stroke as well as strategies for applying new guideline recommendations into practice.

In this podcast, expert clinicians will discuss the association between patent foramen ovale and stroke and review the current clinical data to support PFO closure.

In this podcast, expert clinicians will discuss strategies for classification and workup of cryptogenic stroke and PFO-associated stroke.

In this podcast, expert clinicians will discuss valuable acne management resources for both patients and providers.

In this podcast, expert clinicians will discuss best practices for implementing optimal follow-up care for acne management.

In this podcast, expert clinicians will discuss best practices in selecting acne management while using a patient-centered approach.

In this podcast, expert clinicians will discuss best practices in including the patient/caregiver in clinical decision making for acne management.

In this podcast, expert clinicians will discuss latest clinical evidence from cardiovascular outcomes trials and how reducing triglycerides for further reduces risk.

In this podcast, expert clinicians will discuss evidence regarding mitigating cardiovascular risk by LDL-C reduction.